Back
Amicus Therapeutics Vs. Editas Medicine Industry Stock Comparison
Sell
27
FOLD
Amicus Therapeutics
Last Price:
9.03
Seasonality Move:
24.99%
Sell
47
EDIT
Editas Medicine
Last Price:
5.72
Seasonality Move:
18.83%
Sell
27
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy, Sell or Hold?
- The current Amicus Therapeutics [FOLD] share price is $9.03. The Score for FOLD is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- FOLD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy, Sell or Hold?
- The current Editas Medicine [EDIT] share price is $5.71. The Score for EDIT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- EDIT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FOLD Stock Price Chart
What is Amicus Therapeutics's stock price today?
-
The Amicus Therapeutics share price today is $9.03
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing selling pressure, which indicates risk of future bearish movement.
EDIT Stock Price Chart
What is Editas Medicine's stock price today?
-
The Editas Medicine share price today is $5.71
The current trend is relatively stagnant and EDIT is experiencing slight selling pressure.
FOLD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.48 | Sell |
Relative Strength Index (14 RSI): | 24.19 | Sell |
Chaikin Money Flow: | -2234479 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.84 - 10.98) | Sell |
Bollinger Bands (100): | (10.9 - 13.5) | Sell |
EDIT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.33 | Sell |
Relative Strength Index (14 RSI): | 46.75 | Sell |
Chaikin Money Flow: | -58750 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.22 - 6.16) | Buy |
Bollinger Bands (100): | (6.16 - 9.32) | Sell |
FOLD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.93 | Sell |
20-day SMA: | 10.23 | Sell |
50-day SMA: | 11.15 | Sell |
200-day SMA: | 12.02 | Sell |
8-day EMA: | 9.73 | Sell |
20-day EMA: | 10.22 | Sell |
50-day EMA: | 10.99 | Sell |
200-day EMA: | 11.81 | Sell |
EDIT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.53 | Buy |
20-day SMA: | 5.49 | Buy |
50-day SMA: | 6.81 | Sell |
200-day SMA: | 8.14 | Sell |
8-day EMA: | 5.5 | Buy |
20-day EMA: | 5.7 | Buy |
50-day EMA: | 6.5 | Sell |
200-day EMA: | 8.08 | Sell |
Amicus Therapeutics Earnings Growth & FOLD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.03 per share, an increase this year of $0.46 per share, and an increase next year of $0.45 per share.
Editas Medicine Earnings Growth & EDIT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.41 per share, and an increase next year of $0.04 per share.
Amicus Therapeutics Technical Analysis
Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Editas Medicine Technical Analysis
Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |